Conmed (CNMD) Gross Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 266.00 |
| Dec 31, 2025 | 489.00 |
| Sep 30, 2025 | -706.00 |
| Jun 30, 2025 | 942.00 |
| Mar 31, 2025 | -35.00 |
| Dec 31, 2024 | 373.00 |
| Sep 30, 2024 | 82.00 |
| Jun 30, 2024 | 26.00 |
| Mar 31, 2024 | -54.00 |
| Dec 31, 2023 | 99.00 |
| Sep 30, 2023 | 49.00 |
| Jun 30, 2023 | -90.00 |
| Mar 31, 2023 | -165.00 |
| Dec 31, 2022 | -314.00 |
| Sep 30, 2022 | 118.00 |
| Jun 30, 2022 | 167.00 |
| Mar 31, 2022 | 258.00 |
| Dec 31, 2021 | 448.00 |
| Sep 30, 2021 | 242.00 |
| Jun 30, 2021 | 248.00 |
| Mar 31, 2021 | 126.00 |
| Dec 31, 2020 | 0.00 |
| Sep 30, 2020 | 92.00 |
| Jun 30, 2020 | -606.00 |
| Mar 31, 2020 | 382.00 |
| Dec 31, 2019 | 25.00 |
| Sep 30, 2019 | 59.00 |
| Jun 30, 2019 | 137.00 |
| Mar 31, 2019 | -77.00 |
| Dec 31, 2018 | -4.00 |
| Sep 30, 2018 | 145.00 |
| Jun 30, 2018 | 131.00 |
| Mar 31, 2018 | -69.00 |
| Dec 31, 2017 | 239.00 |
| Sep 30, 2017 | 11.00 |
| Jun 30, 2017 | 51.00 |
| Mar 31, 2017 | 161.00 |
| Dec 31, 2016 | 43.00 |
| Sep 30, 2016 | 193.00 |
| Jun 30, 2016 | 304.00 |
| Mar 31, 2016 | 176.00 |
| Dec 31, 2015 | 420.00 |
| Sep 30, 2015 | 362.00 |
| Jun 30, 2015 | -9.00 |